Skip to content
Disclosery

13F-HR filed by KCK LTD.

KCK LTD. filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-01-31, with 3 holding rows worth $66,746,196.

Accession
0001012975-23-000053
Filer
CIK 1657662
Filed
2023-01-31
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 3 entries on the cover page, a total value of $66,746,196 stated on the cover page (in dollars after the unit check, H1), rows summing to $66,746,196 with VALUE read as dollars as filed, 13F file number 028-21858. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SIGHT SCIENCES INC82657M105COMMON STOCK4,776,232$58,317,793dollars as filed
NEUROPACE INC641288105COMMON STOCK5,621,111$8,375,455dollars as filed
REIN THERAPEUTICS INC00887A204COM NEW22,341$52,948dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-23-000053this filing2023-01-31acceptance time not in the bulk data set